Crossmark

Augmented Cortisol and Antiglucocorticoid Therapy in Mood Disorders: the Hippocampus as a Potential Drug Target

Published Online: 2024-08-29

Published Print: 2024-07

Authors

Gulyaeva, N. V.
License Information

Text and Data Mining valid from 2024-07-01

Version of Record valid from 2024-08-29
More Information

Article History

Received: 26 May 2024

Revised: 12 June 2024

Accepted: 13 June 2024

First Online: 29 August 2024

ADHERENCE TO ETHICAL STANDARDS

: There are no human or animal studies in this paper.

: The author has no relevant financial or non-financial interests to disclose.

Document is current